Physiologically based pharmacokinetic modeling of perfluoroalkyl substances in the human body

Currently, there are limited data on the levels of perfluoroalkyl substances other than perfluorooctane sulfonic acid and perfluorooctanoic acid in the human body. Most of this information has been extracted from biological monitoring of plasma while the occurrence of perfluoroalkyl substances in other human tissues is rarely studied. The objective of the present study was to develop a physiologically based pharmacokinetic model to assess the concentration of perfluoroalkyl substances in human tissues, based on an existing model previously validated for perfluorooctane sulfonic acid and perfluorooctanoic acid. Experimental data on concentrations of perfluoroalkyl substances in human tissues from individuals in Tarragona County (Catalonia, Spain) were used to estimate the values of some distribution and elimination parameters needed for the simulation. No significant correlations were found between these parameters and the chain lengths. The model was finally validated for five perfluoroalkyl substances.     

基于贝叶斯的苯并(α)芘PBPK模型优化与健康风险评估应用

应用基于生理的药代动力学(PBPK)模型预测苯并(α)芘(BaP)暴露的人体内部剂量,基于贝叶斯的马尔科夫链蒙特卡洛模拟(MCMC)方法对模型参数进行校准和优化,最后运用已优化的模型对BaP内暴露基准值进行推导.研究发现,基于贝叶斯的MCMC方法对模型后验参数校准后,模型精度明显提高,两个数据集验证结果显示残差平方和分别降低了72%和94%.PBPK模型以BaP和子代谢物3-羟基苯并(α)芘(3-OHBaP)的体内动力学过程为结构基础,模拟BaP体内浓度分布大小为脂肪>肾脏>皮肤>缓慢灌注组织>快速灌注组织>静脉血>肝脏;3-OHBaP体内浓度分布大小为肾脏>快速灌注组织>脂肪>肺>静脉血>缓慢灌注组织>肝脏>皮肤.敏感性分析显示,快速灌注组织-血分配系数对模型输出影响最大,灵敏度系数超过了200%;排泄系数影响最小,只有肾小球过滤率K_BR的灵敏度系数超过了1%.以美国国家环境保护局推荐的参考浓度2.0×10^-6mg/m³为外暴露安全基准值,基于PBPK模型推导了职业暴露的BaP生物监测当量(BE),结果显示BE值为0.405pmol/mol肌酐(尿液3-OHBaP平均浓度),为基于人体内暴露剂量水平进行定量健康风险评估奠定了基础.     

Feasibility of metabolic parameter estimation in pharmacokinetic models of carbon tetrachloride exposure in rats1

Carbon tetrachloride (CCl₄) is a toxic chemical that was once used in degreasers and detergents, and some remnants of the chemical may be present in the water supply. Physiologically-based pharmacokinetic (PBPK) modeling can assist in understanding resulting internal doses of CCl₄ after exposure, but the pharmacokinetic parameters describing the metabolism of CCl₄ are not well characterized. The goal of this study was to provide insights into how to more accurately estimate these values in rats using PBPK modeling and data from previous studies. Three different PBPK models were constructed to describe CCl₄ exposure in rats via inhalation, oral ingestion, and venous injection. Each of these models was compared to data, and sensitivity analysis was performed for each model to determine whether the available data could be used to accurately determine the metabolic parameters of interest. These parameter sensitivities were so low that optimization to the available data yielded physiologically unrealistic results. Model sensitivities were analyzed for different doses and routes of exposure in order to find experimental conditions that would allow for greater identifiability of the metabolic parameters. Data were simulated from these models at optimal conditions with varying levels of noise from a normal distribution. Optimizations were then performed to confirm that the original values could be obtained. The experiments developed are left as suggestions for investigators who wish to further pursue estimating these metabolic parameters.     

基于PBPK模型评价三氯乙烯的职业暴露健康风险

三氯乙烯(TCE)作为脱脂和清洗剂被广泛应用于五金、电镀和电子等行业。TCE的职业暴露会产生一系列健康风险,包括过敏症和致癌等。2012年TCE被美国环保局(US EPA)和国际癌症研究机构列为1类致癌物。采用吸附管采样-热脱附/气相色谱-质谱法分析了大连市某企业车间生产工况下空气中TCE浓度。基于生理学的药代动力学(PBPK)模型预测了呼吸暴露途径下TCE在职业工人体内组织中的动态分布、代谢产物生成情况和致癌风险。TCE在不同组织中预测的最大浓度呈现出脂肪肠充分灌注室支气管非充分灌注室肝脏静脉血动脉血的趋势。预测的与致癌有关的代谢产物最大浓度表现为三氯乙酸二氯乙酸三氯乙醛S-二氯乙烯基-L-半胱氨酸。在监测的TCE水平(39.2±24.4)μg·m-3下,暴露8 h·d-1,连续暴露20年,基于外暴露评价的职业工人致癌风险均值为1.31×10-5,该暴露水平下,基于PBPK模型预测的TCE内暴露与外暴露计算的致癌风险水平相近,但基于具有致癌性主要代谢产物的内暴露致癌风险值是外暴露风险值的1.17～1.73倍。TCE的暴露水平越高,基于内暴露方法和外暴露方法的致癌风险评价结果差异越大。敏感性分析表明,心输出血流量和充分灌注室血流量对PBPK模型输出结果具有重要影响。不确定性分析表明,模型参数变化会显著地影响PBPK模型输出结果,但变异在可接受水平。本研究结果说明,评价TCE暴露对人的致癌风险需要考虑其在体内的分布和代谢过程。     

基于PBPK模型的大鼠体内镉分布的比较:联合暴露及单独暴露

环境中同时存在着多种重金属元素,联合暴露与单独暴露时,重金属在体内的蓄积分布情况也可能有所差异。为探究重金属元素(汞、铬、砷、铅)对镉(Cd)在体内分布的影响,建立了大鼠在Cd暴露下的药代动力学(PBPK)模型,并进行了包括Cd在内5种重金属的联合毒性实验,比较了Cd单独给药与重金属混合物给药2种方式下大鼠肝脏、肾脏中的Cd浓度水平。结果表明,联合暴露高(Hg Cl23.67 mg·kg~(-1),NaAsO_2 3.67 mg·kg~(-1),CdCl_2 10.55 mg·kg~(-1),K_2Cr_2O_7 6.40 mg·kg~(-1),Pb(OOCCH_3)_2·3H_2O 133.33 mg·kg~(-1))、中(HgCl_20.367 mg·kg~(-1),NaAsO_2 0.367 mg·kg~(-1),CdCl_2 1.055 mg·kg~(-1),K2Cr2O70.640 mg·kg~(-1),Pb(OOCCH_3)_2·3H_2O 13.333 mg·kg~(-1))、低(HgCl_2 0.0367 mg·kg~(-1),Na As O20.0367 mg·kg~(-1),Cd Cl20.1055 mg·kg~(-1),K_2Cr_2O_7 0.0640 mg·kg~(-1),Pb(OOCCH3)2·3H2O 1.3333 mg·kg~(-1))剂量组大鼠肝脏中Cd浓度分别为13.37、0.78和0.06μg·g~(-1);肾脏中Cd浓度分别为14.41、1.64和0.15μg·g~(-1)。与对照组相比,暴露组中Cd浓度有显著升高,且不同剂量组之间均有显著性差异。同剂量Cd单独暴露的PBPK模拟结果显示,肝脏及肾脏中的Cd浓度水平落在联合毒性实验结果的浓度范围内,初步推断其他4种重金属的联合暴露并没有影响Cd在大鼠肾脏和肝脏中的浓度分布。     

Malathion dermal permeability in relation to dermal load: Assessment by physiologically based pharmacokinetic modeling of in vivo human data

Estimates of dermal permeability (K_p), obtained by fitting an updated human PBPK model for malathion to previously reported data on excreted urinary metabolites after 29 volunteers were dermally exposed to measured values of [¹⁴C]malathion dermal load (L), were used to examine the empirical relationship between K_p and L. The PBPK model was adapted from previously reported human biokinetic and PBPK models for malathion, fit to previously reported urinary excretion data after oral [¹⁴C]malathion intake by volunteers, and then augmented to incorporate a standard K_p approach to modeling dermal-uptake kinetics. Good to excellent PBPK-model fits were obtained to all of 29 sets of cumulative urinary metabolite-excretion data (ave. [±1 SD] R² = 0.953 [±0.064]). Contrary to the assumption that K_p and L are independent typically applied for dermally administered liquids or solutions, the 29 PBPK-based estimates of K_p obtained for malathion exhibit a strong positive association with the 2/3rds power of L (log-log Pearson correlation = 0.925, p = ～0). Possible explanations of this observation involving physico-chemical characteristics and/or in vivo cutaneous effects of malathion are discussed. The PBPK model presented, and our observation that K_p estimates obtained by fitting this model to human experimental urinary-excretion data correlate well with L^2/3, allow more realistic assessments of absorbed and metabolized dose during or after a variety of scenarios involving actual or potential dermal or multi-route malathion exposures, including for pesticide workers or farmers who apply malathion to crops.     

Physiological changes associated with aging result in lower internal doses of toluene and perchloroethylene in simulations using pharmacokinetic modeling

Physiologically based pharmacokinetic (PBPK) models were developed in order to translate external concentrations into internal dose estimates, but most PBPK models were developed for younger adults. A set of physiological parameters for ages 65, 75, and 85 of both genders were developed and were used with previously established human PBPK models of exposure to toluene and perchloroethylene (PERC) in order to investigate internal dose changes with increasing age. The predicted compartmental concentrations of toluene and PERC for aged adults were lower than predicted concentrations for younger adults, and this suggests that body composition changes with aging do not increase internal doses of inhaled toxicants alone after acute exposure. Hence, susceptibility to either toxicant was not expected to increase solely based on the physiological changes associated with aging. Predictions for a metabolite of PERC, however, were similar in magnitude across ages, which may lead to enhanced susceptibility if metabolic capacity changes with aging.     

Transport and dynamics of toxic pollutants in the natural environment and their effect on human health: research gaps and challenge

The source–pathway–receptor (SPR) approach to human exposure and risk assessment contains considerable uncertainty when using the refined modelling approaches to pollutant transport and dispersal, not least in how compounds of concern might be prioritised, proxy or indicator substances identified and the basic environmental and toxicological data collected. The impact of external environmental variables, urban systems and lifestyle is still poorly understood. This determines exposure of individuals and there are a number of methods being developed to provide more reliable spatial assessments. Within the human body, the dynamics of pollutants and effects on target organs from diffuse, transient sources of exposure sets ambitious challenges for traditional risk assessment approaches. Considerable potential exists in the application of, e.g. physiologically based pharmacokinetic (PBPK) models. The reduction in uncertainties associated with the effects of contaminants on humans, transport and dynamics influencing exposure, implications of adult versus child exposure and lifestyle and the development of realistic toxicological and exposure data are all highlighted as urgent research needs. The potential to integrate environmental with toxicological models provides the next phase of research opportunity and should be used to drive empirical and model assessments.     

烧烤场景中基于PBPK模型的人群PAHs暴露评估

为探究烧烤场景中人群多环芳烃(PAHs)的暴露特征与健康风险,使用美国环保署推荐的计算模型和基于生理的药代动力学模型(PBPK)模拟了我国人群的PAHs外暴露剂量和健康风险以及内暴露剂量变化情况。结果表明:1)普通居民和职业人群的日均苯并[a]芘等效摄入剂量为(50±3)ng·d~(-1)和(179±98)ng·d~(-1),其终生致癌风险为7.57×10~(-7)~1.28×10~(-5),均在可接受范围内;2)普通居民暴露后体内组织中PAHs内暴露标志物芘的最大浓度范围依次为肝(6.52~8.67 ng·L~(-1))肾(0.97~1.12 ng·L~(-1))静脉血(0.71~0.94 ng·L~(-1))皮肤(0.64~0.75 ng·L~(-1))脂肪(0.36~0.56 ng·L~(-1)),职业人群暴露后体内组织芘最大浓度为脂肪(2.97ng·L~(-1))皮肤(1.14 ng·L~(-1))≥肾(1.14 ng·L~(-1))肝(0.57 ng·L~(-1))静脉血(0.17 ng·L~(-1));3)膳食是普通人群的主导暴露途经,会导致肝组织浓度最大;呼吸和皮肤接触是职业人群的主导暴露途经,会导致脂肪组织浓度最大;4)暴露标志物芘的组织总富集量关系为职业人群(48 ng·d~(-1))大于普通人群(6~11 ng·d~(-1))。     

苯暴露的致癌风险评价

为建立苯暴露风险的定量研究方法,利用生理药代动力学(PBPK)模型与剂量—反应关系,进行苯暴露的致癌风险评价。采用美国环保署推荐的PBPK模型模拟软件,计算苯经吸收转化后进入人体的数据。将模拟得到的内剂量代入致癌风险计算公式中,得到苯暴露的致癌风险,并利用蒙特卡洛模拟方法确定风险概率分布,进行不确定性分析。最后将此健康风险评价方法应用于天津某大型石油化工企业,分析工人苯暴露下的致癌风险。结果表明,工人苯暴露的致癌风险明显超过了最大可接受风险值1×10-4,需要采取相关措施降低风险。